When I first introduced HSKA in last December, the share price was once hovering around $ 0.5, but soon broke through the resistance following the earning report and once reached $1. Now here comes the moment for PDEX: fiscal third quarter earning report of 2010 will be released on this Thursday (04/29/2010) after market close.
PDEX successfully turned from loss to profit in last quarter and it is expected to report a second profitable quarter in a row. Once it comes true, we may see a big rally of its share price.
About Pro-Dex, Inc. (PDEX)
PDEX specializes in the development and manufacture of technology-based solutions that incorporate embedded motion control, miniature rotary drive systems, and fractional horsepower DC motors, serving the medical, dental, semiconductor, scientific research and aerospace markets.
The company’s products are used in hospitals, dental offices, medical engineering labs, scientific research facilities and high tech manufacturing operations around the world.
NASDAQ Listing Issue:
When some of the investors were nervous about the NASDAQ listing qualification last month, I predicted that PDEX would get 6 months grace period based on the company’s fundamentals and prospect. As we already known, the NASDAQ Listing Qualifications Panel has granted the Company's request early this month for continued listing on The NASDAQ Capital Market until July 12, 2010 to remain compliance. But I don’t think that PDEX will need that long to go above the $1threshold. It can be as soon as this week if PDEX simply comes out with a transcript in line with expectation.
Upcoming Events:
Medical Device&Diagnostics Executive Minneapolis, MNMay 20 - 21, 2010
OMTEC2010 Chicago, ILJune 16-17, 2010
FIME 2010 Miami Beach, FLAugust 11 - 13, 2010
Any good news of collaboration or new orders from these conferences and expos can easily double up PDEX’s share price, especially when its current price is seriously undervalued.The U.S. stock market plunged yesterday, but PDEX still edged up 1.6%. It reflected the market’s confidence on its earning prospect to some extent.
So will PDEX skyrocket with a satisfactory earning transcript like HSKA? The riddle will be answered soon.
For more information of PDEX, please find my previous posts in my blog.
*Disclaimer: The author of this post is not a licensed analyst and the purpose of it is for information sharing and discussion only, not recommendation for any stock buying and selling activity. Please do your own decent research before making any trading decision

Read AndrewGreenBull's blog in RSS
April 28, 2010
Share This